10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2014 | |||
Consolidated Statement of Earnings | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 27, 2015) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Net Sales | $ 20,247 | 19,657 | 19,050 |
| Cost of products sold, excluding amortization of intangible assets | 9,218 | 9,193 | 8,899 |
| Amortization of intangible assets | 555 | 588 | 595 |
| Research and development | 1,345 | 1,371 | 1,461 |
| Selling, general and administrative | 6,530 | 6,372 | 6,735 |
| Total Operating Cost and Expenses | 17,648 | 17,524 | 17,690 |
| Operating Earnings | 2,599 | 2,133 | 1,360 |
| Interest expense | 150 | 145 | 320 |
| Interest income | (77) | (67) | (59) |
| Net loss on extinguishment of debt | 18 | 1,351 | |
| Net foreign exchange (gain) loss | (24) | 46 | (31) |
| Other (income) expense, net | 14 | (32) | (1) |
| Earnings (loss) from Continuing Operations before Taxes | 2,518 | 2,041 | (220) |
| Taxes on Earnings (loss) from Continuing Operations | 797 | 53 | (457) |
| Earnings from Continuing Operations | 1,721 | 1,988 | 237 |
| Earnings from Discontinued Operations, net of taxes | 563 | 588 | 5,726 |
| Net Earnings | 2,284 | 2,576 | 5,963 |
| Basic Earnings Per Common Share | |||
| Continuing Operations (in dollars per share) | 1.13 | 1.27 | 0.15 |
| Discontinued Operations (in dollars per share) | 0.37 | 0.37 | 3.61 |
| Net Earnings (in dollars per share) | 1.50 | 1.64 | 3.76 |
| Diluted Earnings Per Common Share | |||
| Continuing Operations (in dollars per share) | 1.12 | 1.26 | 0.15 |
| Discontinued Operations (in dollars per share) | 0.37 | 0.36 | 3.57 |
| Net Earnings (in dollars per share) | 1.49 | 1.62 | 3.72 |
| Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) | 1,516 | 1,558 | 1,575 |
| Dilutive Common Stock Options and Awards (in shares) | 11 | 16 | 17 |
| Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options and Awards (in shares) | 1,527 | 1,574 | 1,592 |
| Outstanding Common Stock Options Having No Dilutive Effect (in shares) | 1 | 1 | 1 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2014 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |